Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder for which numerous mouse models have been generated. In both AD patients and mouse models, there is increasing evidence that neuronal dysfunction occurs before the accumulation of β-amyloid (Aβ)-containing plaques and neurodegeneration. Characterization of the timing and nature of preplaque dysfunction is important for understanding the progression of this disease and to identify pathways and molecular targets for therapeutic intervention. Hence, we have examined the progression of dysfunction at the morphological, functional, and behavioral levels in the Tg2576 mouse model of AD. Our data show that decreased dendritic spine density, impaired long-term potentiation (LTP), and behavioral deficits occurred months before plaque deposition, which was first detectable at 18 months of age. We detected a decrease in spine density in the outer molecular layer of the dentate gyrus (DG) beginning as early as 4 months of age. Furthermore, by 5 months, there was a decline in LTP in the DG after perforant path stimulation and impairment in contextual fear conditioning. Moreover, an increase in the Aβ42/Aβ40 ratio was first observed at these early ages. However, total amyloid levels did not significantly increase until ≈18 months of age, at which time significant increases in reactive astrocytes and microglia could be observed. Overall, these data show that the perforant path input from the entorhinal cortex to the DG is compromised both structurally and functionally, and this pathology is manifested in memory defects long before significant plaque deposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas high-frequency stimulation significantly increased the magnitude of long-term potentiation (LTP) at Schaffer collateral (SC)-CA1 synapses in the hippocampus of wild type (WT) mice, LTP was significantly impaired in 6-to 7-mo-old APP/PS1 mice (17,18).”
From IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline (2016) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is different from the progression in Tg2576, which manifests synaptic damage at an early stage of pathological development (4.5 months) [68,69] with a corresponding decrease in synaptic density markers [70] prior to Aβ plaque development (10 months) [71] and cognitive deficiencies (one year) [72,73].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [69]
The cited source says what the claim attributes to it.
In the citing paper
“Tg2576 mice began to show impaired LTP and synaptic transmission in dentate gyrus (DG) at 4–5 mo or older (Jacobsen et al., 2006).”
From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Jacobsen et al., 2006
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Life and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344
Self-citationDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Cited by
Items 401–500 of 789
Inaba, H., Kishimoto, T. E., Oishi, S., Nagata, K., Hasegawa, S., Watanabe, T., & Kida, S. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1224639 · Cited by 30
Altered phosphorylation but no neurodegeneration in a mouse model of tau hyperphosphorylation
Hundelt, M., Fath, T., Selle, K., Oesterwind, K., Jordan, J., Schultz, C., Götz, J., von Engelhardt, J., Monyer, H., Lewejohann, L., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.007 · Cited by 30
Ali, M., Huarte, O. U., Heurtaux, T., Garcia, P., Rodriguez, B. P., Grzyb, K., Halder, R., Skupin, A., Buttini, M., & Glaab, E. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02985-2 · Cited by 29
Díaz, A., Merino, P., Guo, J., Yepes, M., McCann, P., Katta, T., Tong, E. M., Torre, E. R., Rangaraju, S., & Yepes, M. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2804-19.2020 · Cited by 29
Lim, C. S., & Alkon, D. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097756 · Cited by 29
Modulation of hippocampal calcium signalling and plasticity by serine/threonine protein phosphatases
Koss, D. J., Hindley, K. P., Riedel, G., & Platt, B. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04579.x · Cited by 29
Gelsolin as therapeutic target in Alzheimer's disease
Carro, E. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.488222 · Cited by 30
Early diagnostics and therapeutics for Alzheimer’s disease – how early can we get there?
Monien, B. H., Apostolova, L. G., & Bitan, G. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.9.1293 · Cited by 30
Intraneuronally injected amyloid beta inhibits long-term potentiation in rat hippocampal slices
Nomura, I., Takechi, H., & Kato, N. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00589.2011 · Cited by 28
Yousefi, N., Sotoodehnejadnematalahi, F., Heshmati-Fakhr, N., Sayyah, M., Hoseini, M., Ghassemi, S., Aliakbari, S., & Pourbadie, H. G. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1249-1 · Cited by 28
Cuadrado‐Tejedor, M., Cabodevilla, F., Zamarbide, M., Gómez‐Isla, T., Franco, R., & Pérez‐Mediavilla, A. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310040005 · Cited by 28
Possible epigenetic regulatory effect of dysregulated circular RNAs in Alzheimer’s disease model
Lee, W. J., Moon, J., Jeon, D., Shin, Y., Yoo, J.-S., Park, D.-K., Lee, S., Jung, K., Park, K., Jung, K., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48471-z · Cited by 28
Ai, P.-H., Chen, S. X., Liu, X., Zhu, X., Pan, Y., Feng, D., Chen, S., Xu, N., & Sun, S. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00194-2 · Cited by 28
Sell, G. L., Schaffer, T. B., & Margolis, S. S. (2017) · Journal of Clinical Investigation · doi:10.1172/jci85504 · Cited by 28
Qin, T., Prins, S., Groeneveld, G. J., van Westen, G. J. P., de Vries, H. E., Wong, Y. C., Bischoff, L. J. M., & de Lange, E. C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093158 · Cited by 27
Evidence of disturbed insulin signaling in animal models of Alzheimer’s disease
Alves, S. S., Servilha‐Menezes, G., Rossi, L., da Silva-Júnior, R. M. P., & Garcia‐Cairasco, N. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105326 · Cited by 27
Hanson, J. E., Meilandt, W. J., Gogineni, A., Reynen, P., Herrington, J. B., Weimer, R. M., Scearce-Levie, K. A., & Zhou, Q. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5106-13.2014 · Cited by 27
Melatonin in Synaptic Impairments of Alzheimer’s Disease
Shi, Y., Fang, Y., Wei, Y., Jiang, Q., Zeng, P. H., Tang, N., Lu, Y., & Tian, Q. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171178 · Cited by 27
Alcantara‐Gonzalez, D., Chartampila, E., Criscuolo, C., & Scharfman, H. E. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105274 · Cited by 27
Hanson, J. E., & Madison, D. V. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-96 · Cited by 27
Lisgaras, C. P., & Scharfman, H. E. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106294 · Cited by 26
Tamagnini, F., Burattini, C., Casoli, T., Balietti, M., Fattoretti, P., & Aicardi, G. (2012) · Rejuvenation Research · doi:10.1089/rej.2011.1311 · Cited by 26
Panel of synaptic protein ELISAs for evaluating neurological phenotype
Gottschall, P. E., Ajmo, J. M., Eakin, A. K., Howell, M. D., Mehta, H. N., & Bailey, L. A. (2010) · Experimental Brain Research · doi:10.1007/s00221-010-2182-x · Cited by 26
Huang, Y., Guo, B., Shi, B., Gao, Q., & Zhou, Q. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170763 · Cited by 28
Klein, W. L., Lacor, P. N., Felice, F. G. D., & Ferreira, S. T. (2007) · Research and perspectives in neurosciences · doi:10.1007/978-3-540-45702-2_11 · Cited by 25
Malter, J. S. (2022) · Translational research · doi:10.1016/j.trsl.2022.09.003 · Cited by 25
Asim, M., Wang, H., Waris, A., Qianqian, G., & Chen, X. (2024) · BioFactors · doi:10.1002/biof.2081 · Cited by 25
Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's disease
Paul, J. R., Munir, H. A., van Groen, T., & Gamble, K. L. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.007 · Cited by 25
Impairment of spatial memory consolidation in APP751SL mice results in cue-guided response
Blanchard, J., Martel, G., Guillou, J., Noguès, X., & Micheau, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.010 · Cited by 25
Stobart, M. J., Parchaliuk, D. L., Simon, S. L. R., Stobart, J. L., Lazar, J., Rubenstein, R., & Knox, J. D. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-5 · Cited by 25
New Hope from an Old Drug: Fighting Alzheimer's Disease with the Cancer Drug Bexarotene (Targretin)?
Aicardi, G. (2013) · Rejuvenation Research · doi:10.1089/rej.2013.1497 · Cited by 25
Intracerebral Nanoparticle Transport Facilitated by Alzheimer Pathology and Age
Tracy, G. C., Huang, K.-Y., Hong, Y.-T., Ding, S., Noblet, H. A., Lim, K. H., Kim, E. C., Chung, H. J., & Kong, H. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c03222 · Cited by 24
Cortez, I., Hernandez, C. M., & Dineley, K. T. (2020) · Brain and Behavior · doi:10.1002/brb3.1973 · Cited by 24
Chiantia, G., Hidişoğlu, E., & Marcantoni, A. (2023) · Cells · doi:10.3390/cells12091236 · Cited by 24
Fitzjohn, S. M., Kuenzi, F. M., Morton, R. A., Rosahl, T. W., Lewis, H. D., Smith, D., Seabrook, G. R., & Collingridge, G. L. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-21 · Cited by 24
Li, W., Jin, L., Li, Y.-P., Feng, Q., Ren, L., Wang, F., & Bo, G.-J. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.239448 · Cited by 24
Mitophagy and iron: two actors sharing the stage in age-associated neuronal pathologies
Schiavi, A., Strappazzon, F., & Ventura, N. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111252 · Cited by 24
Wu, W., Zheng, T., & Tian, Y. (2020) · Chemical Communications · doi:10.1039/d0cc01971b · Cited by 24
Bailey, J. A., & Lahiri, D. K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1377.001 · Cited by 24
Chartampila, E., Elayouby, K. S., Leary, P., LaFrancois, J. J., Alcantara‐Gonzalez, D., Jain, S. S., Gerencer, K., Botterill, J. J., Ginsberg, S. D., & Scharfman, H. E. (2024) · eLife · doi:10.7554/elife.89889 · Cited by 23
Genetic Animal Models of Cerebral Vasculopathies
Lee, J. H., Bacskai, B. J., & Ayata, C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00002-0 · Cited by 24
The Mevalonate Pathway in Alzheimer’s Disease — Cholesterol and Non-Sterol Isoprenoids
Mohamed, A., Smith, K. T., & Chaves, E. (2015) · InTech eBooks · doi:10.5772/59904 · Cited by 24
Perhoč, A. B., Barilar, J. O., Knezović, A., Farkaš, V., Bagarić, R., Švarc, A., Grünblatt, E., Riederer, P., & Šalković‐Petrišić, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.018 · Cited by 24
Yang, Q., Song, D. F., Xie, Z., He, G., Zhao, J., Wang, Z., Dong, Z., Zhang, H., Yang, L., Jiang, M., et al. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102209 · Cited by 23
Cassel, J., Mathis, C., Majchrzak, M. J., Moreau, P., & Dalrymple‐Alford, J. C. (2008) · Neurodegenerative Diseases · doi:10.1159/000135615 · Cited by 23
Good, M. A., & Hale, G. (2007) · Behavioral Neuroscience · doi:10.1037/0735-7044.121.6.1180 · Cited by 22
He, A., Zhang, C., Ke, X., Yao, Y., Yu, Q., Zhang, T., Yu, H., Du, H., Li, H., Tian, Q., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2047-8 · Cited by 22
Bezzina, C., Verret, L., Halley, H., Dahan, L., & Rampon, C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00178 · Cited by 22
Kishimoto, Y., Higashihara, E., Fukuta, A., Nagao, A., & Kirino, Y. (2012) · Brain Research · doi:10.1016/j.brainres.2012.10.066 · Cited by 22
Lim, C. S., & Han, J. (2018) · Bioscience Reports · doi:10.1042/bsr20171611 · Cited by 22
Zhang, L., Tang, W. X., Chao, F., Zhou, C., Jiang, L. H., Zhang, Y., Liang, X., Tang, J., Qi, Y., Yang, H., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104723 · Cited by 22
Chen, L., Christenson Wick, Z., Vetere, L. M., Vaughan, N., Jurkowski, A., Galas, A., Diego, K. S., Philipsberg, P. A., Soler, I., Feng, Y., et al. (2023) · The Journal of Neuroscience · doi:10.1523/jneurosci.1204-23.2023 · Cited by 21
“In these mice, perforant path input was also compromised both structurally and functionally before detectable plaque deposition (Jacobsen et al., 2006), suggesting early changes in entorhinal inputs to hippocampus.”
BackgroundEstévez-Silva, H. M., Cuesto, G., Romero, N., Armas, J. M. B., Acevedo‐Arozena, A., Acebes, Á., & Marcellino, D. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01280-1 · Cited by 21
Localized APP expression results in progressive network dysfunction by disorganizing spike timing
da Silva, S. V., Haberl, M. G., Gaur, K., Patel, R., Narayan, G., Ledakis, M., Fu, M. L., Vieira, M. D. C., Koo, E. H., Leutgeb, J. K., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.10.001 · Cited by 22
Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects
Collins, H. M., & Greenfield, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116222 · Cited by 21
c-Abl Deficiency Provides Synaptic Resiliency Against Aβ-Oligomers
Gutiérrez, D. A., Vargas, L. M., Chandía-Cristi, A., de la Fuente, C., Leal, N. R., & Alvarez, A. R. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00526 · Cited by 21
Hossain, M. S., Oomura, Y., & Katafuchi, T. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0578-3 · Cited by 21
Progressive sleep disturbance in various transgenic mouse models of Alzheimer’s disease
Drew, V. J., Wang, C., & Kim, T. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1119810 · Cited by 20
Dubner, L., Wang, J., Ho, L., Ward, L. M., & Pasinetti, G. M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150536 · Cited by 20
Lv, L., Wang, Y., Feng, W., Hernández, J. A., Huang, W., Zheng, Y., Zhou, X., Lv, S., Chen, Y., & Yuan, Z. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.03.012 · Cited by 20
Drebrin and cognitive impairment
Ma, L., Li, Y., & Wang, R. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.06.021 · Cited by 20
Nakanishi, N., Ryan, S. D., Zhang, X., Khan, A. U., Holland, T., Cho, E.-G., Huang, X., Liao, F., Xu, H., Lipton, S. A., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4646-10.2013 · Cited by 20
Richards, G. J., Messer, J., Faull, R. L. M., Stadler, H., Wichmann, J., Huguenin, P. N., Bohrmann, B., & Mutel, V. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.072 · Cited by 20
Aβ Infusion and Related Models of Alzheimer Dementia
Lawlor, P. A., & Young, D. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_17 · Cited by 20
Szatmari, E. M., Moran, C., Cohen, S. J., Jacob, A., Parra-Bueno, P., Kamasawa, N., Guerrero‐Given, D., Klein, M., Stackman, R. W., & Yasuda, R. (2020) · eNeuro · doi:10.1523/eneuro.0111-20.2020 · Cited by 19
Honey and Alzheimer’s Disease—Current Understanding and Future Prospects
Shaikh, A., Ahmad, F., Teoh, S. L., Kumar, J., & Yahaya, M. F. (2023) · Antioxidants · doi:10.3390/antiox12020427 · Cited by 19
Cohen, E. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10088 · Cited by 19
Szabo, A. B., Cattaud, V., Bezzina, C., Dard, R. F., Sayegh, F. J. P., Gauzin, S., Lejards, C., Valton, L., Rampon, C., Verret, L., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.11.017 · Cited by 19
Blanchard, J., Decorte, L., Noguès, X., & Micheau, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.02.005 · Cited by 19
Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNA
Sénéchal, Y., Prut, L., Kelly, P. H., Staufenbiel, M., Natt, F., Hoyer, D., Wießner, C., & Dev, K. K. (2008) · Brain Research · doi:10.1016/j.brainres.2008.09.024 · Cited by 19
Early hippocampal hyperexcitability and synaptic reorganization in mouse models of amyloidosis
Ray, A., Loghinov, I., Ravindranath, V., & Barth, A. L. (2024) · iScience · doi:10.1016/j.isci.2024.110629 · Cited by 18
The Amyloid Precursor Protein Intracellular Domain Is an Effector Molecule of Metaplasticity
Trillaud-Doppia, É., & Boehm, J. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.12.015 · Cited by 18
Cope, Z. A., Murai, T., & Rizzo, S. J. S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.805063 · Cited by 18
Scherzer‐Attali, R., Convertino, M., Pellarin, R., Gazit, E., Segal, D., & Caflisch, A. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp309066p · Cited by 18
Defined astrocytic expression of human amyloid precursor protein in Tg2576 mouse brain
Heiland, T., Zeitschel, U., Puchades, M. A., Kuhn, P., Lichtenthaler, S. F., Bjaalie, J. G., Hartlage‐Rübsamen, M., Roßner, S., & Höfling, C. (2018) · Glia · doi:10.1002/glia.23550 · Cited by 18
Molecular mechanisms implicated in protein changes in the Alzheimer’s disease human hippocampus
Nguyen, H. D., Kim, W.-K., & Vu, G. H. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111930 · Cited by 18
Maternal imprinting on cognition markers of wild type and transgenic Alzheimer’s disease model mice
Zamarbide, M., Gil-Bea, F. J., Bannenberg, P., Martínez‐Pinilla, E., Sandoval, J., Franco, R., & Pérez‐Mediavilla, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-24710-7 · Cited by 17
Kalirin‐7 prevents dendritic spine dysgenesis induced by amyloid beta‐derived oligomers
Xie, Z., Shapiro, L. P., Cahill, M. E., Russell, T. A., Lacor, P. N., Klein, W. L., & Penzes, P. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14311 · Cited by 17
Wander, C. M., Li, Y., Bao, H., Asrican, B., Luo, Y., Sullivan, H. A., Chao, T.-H. H., Zhang, W., Chéry, S. L., Tart, D. S., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04078-7 · Cited by 17
Cavanagh, C., Colby-Milley, J., Farso, M. C., Krantic, S. M., & Quirion, R. (2011) · Future Neurology · doi:10.2217/fnl.11.50 · Cited by 17
Neural network plasticity, BDNF and behavioral interventions in Alzheimer's disease
Hubka, P. (2006) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656858 · Cited by 17
Willis, M., Prokesch, M., Hutter‐Paier, B., Windisch, M., Stridsberg, M., Mahata, S. K., Kirchmair, R., Wietzorrek, G., Knaus, H., Jellinger, K. A., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13202 · Cited by 18
Retromer dysfunction at the nexus of tauopathies
Carosi, J. M., Denton, D., Kumar, S., & Sargeant, T. J. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00727-2 · Cited by 16
Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective
Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 16
Tzavellas, N. P., Tsamis, K. I., Katsenos, A. P., Davri, A. S., Simos, Y. V., Nikas, I. P., Bellos, S., Lekkas, P., Kanellos, F. S., Konitsiotis, S., et al. (2024) · Cells · doi:10.3390/cells13050434 · Cited by 16
Lachén‐Montes, M., González-Morales, A., Alonso, M. P., Ausín, K., Gómez-Ochoa, M., Zelaya, M. V., Ferrer, I., Pérez‐Mediavilla, A., Fernández‐Irigoyen, J., & Santamaría, E. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00141 · Cited by 16
Sekioka, R., Honda, S., Akashiba, H., Yarimizu, J., Mitani, Y., & Yamasaki, S. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115455 · Cited by 16
Yu, Y., Wang, W., Chen, A., Chang, Q., Liu, S., Zhao, M., Wang, S., Qiu, W., Pang, X., Xu, Q., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132177 · Cited by 16
Benzothiazole Amphiphiles Promote the Formation of Dendritic Spines in Primary Hippocampal Neurons
Cifelli, J. L., Dozier, L. E., Chung, T. S., Patrick, G. N., & Yang, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.701482 · Cited by 16
Ono, K., Zhao, D., Wu, Q., Simon, J. E., Wang, J., Radu, A., & Pasinetti, G. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-190543 · Cited by 16
Falinska, A. M., Bascoul-Colombo, C., Guschina, I. A., Good, M. A., & Harwood, J. L. (2011) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2011.09.001 · Cited by 16
Alonso, M. P., Lachén‐Montes, M., González-Morales, A., Ausín, K., Pérez‐Mediavilla, A., Fernández‐Irigoyen, J., & Santamaría, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112260 · Cited by 16
Klonarakis, M., Vos, M. D., Woo, E. K., Ralph, L. T., Thacker, J. S., & Gil‐Mohapel, J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104541 · Cited by 15
Heshmati-Fakhr, N., Sotoodehnejadnematalahi, F., Yousefi, N., Sayyah, M., Hosseini, S. M., & Pourbadie, H. G. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001132 · Cited by 16
Long‐term perturbation of spine plasticity results in distinct impairments of cognitive function
VanLeeuwen, J., & Penzes, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07899.x · Cited by 15
Middei, S., Restivo, L., Caprioli, A., Aceti, M., & Ammassari‐Teule, M. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.04.008 · Cited by 15
Reichenstein, M., Borovok, N., Sheinin, A., Brider, T., & Michaelevski, I. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00858-7 · Cited by 14
Landry, O., François, A., Mi-mba, M.-F. O. M., Traversy, M.-T., Tremblay, C., Émond, V., Bennett, D. A., Gylys, K. H., Buxbaum, J. D., & Calon, F. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1945-22.2023 · Cited by 14
A current view of Alzheimer's disease
Hooli, B. V., & Tanzi, R. E. (2009) · F1000 Biology Reports · doi:10.3410/b1-54 · Cited by 14
Zhang, Y., Chao, F., Zhang, L., Jiang, L. H., Zhou, C., Chen, L., Lü, W., Jiang, R., & Tang, Y. C. (2019) · Brain and Behavior · doi:10.1002/brb3.1268 · Cited by 14
Metadata
- Authors
- Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., & Bloom, F. E.
- Affiliations
- Wyeth (US)
- Neurome, Inc., La Jolla, CA 92037; and
- Icahn School of Medicine at Mount Sinai (US)
- Scripps Research Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-03-20
- Volume
- 103
- Issue
- 13
- Pages
- 5161-5166
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1405622
- OpenAlex
- W2136901555
- Cited by
- 701
- References
- 44
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 26 · 2023: 31 · 2022: 24 · 2021: 32 · 2020: 26 · 2019: 32 · 2018: 35 · 2017: 28 · 2016: 42 · 2015: 26 · 2014: 40 · 2013: 35 · 2012: 46
- FWCI
- 30.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, dendritic spine density, long-term potentiation, dentate gyrus, perforant path, contextual fear conditioning, memory impairment, amyloid-beta 42/40 ratio, amyloid plaques, reactive astrocytes, microglia, entorhinal cortex
- MeSH terms
- Aging, Alzheimer Disease, Animals, Behavior, Animal, Brain, Disease Models, Animal, Fear, Memory, Mice, Transgenic, Organ Size, Spine, Synapses, Time Factors, Amyloid beta-Peptides, Synaptophysin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.